Literature DB >> 8427498

Laser-Doppler measurements and electrocochleography during ischemia of the guinea pig cochlea: implications for hearing preservation in acoustic neuroma surgery.

R A Levine1, N Bu-Saba, M C Brown.   

Abstract

Interruption of cochlear blood flow has been implicated as one of the causes of the sensorineural hearing loss that may occur during acoustic neuroma surgery. With the guinea pig as an animal model for cerebellopontine angle surgery, laser-Doppler measurements were used to estimate the cochlear blood flow changes caused by compression of the eighth nerve complex. With compression, the laser-Doppler measurements decreased abruptly; somewhat later, the electrocochleographic potentials declined. When compression was released, laser-Doppler measurements usually returned immediately, followed later by return of the electrical potentials. Some of these potentials, including the compound action potential of the auditory nerve, often became transiently larger than their precompression values. Interposing bone between the laser-Doppler probe and the otic capsule, so that the total bone thickness approximated the thickness of the human otic capsule, decreased the laser-Doppler measurement, but changes caused by compression were still apparent. Thus, although the human otic capsule is much thicker than the guinea pig capsule, it may still be possible to make laser-Doppler estimates of human cochlear blood flow. Laser-Doppler monitoring during acoustic neuroma surgery may be beneficial, because it could give earlier warning of ischemia than is currently available from electrocochleographic monitoring, thereby enabling earlier corrective action. Electrocochleography complements laser-Doppler measurements by indicating the physiologic state of the cochlea.

Entities:  

Mesh:

Year:  1993        PMID: 8427498     DOI: 10.1177/000348949310200210

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  8 in total

1.  Neuromonitoring of cochlea and auditory nerve with multiple extracted parameters during induced hypoxia and nerve manipulation.

Authors:  Jorge Bohórquez; Ozcan Ozdamar; Krzysztof Morawski; Fred F Telischi; Rafael E Delgado; Erdem Yavuz
Journal:  J Neural Eng       Date:  2005-03-08       Impact factor: 5.379

2.  Thermal effects of cold light sources used in otologic surgery.

Authors:  Fadlullah Aksoy; Remzi Dogan; Orhan Ozturan; Sabri Baki Eren; Bayram Veyseller; Ozge Gedik
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-14       Impact factor: 2.503

3.  Auditory brainstem response findings in brainstem ischemia following selective occlusion of the anterior inferior cerebellar artery in the rat.

Authors:  H Inui; T Murai; T Matsunaga
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  Simultaneous measurement of electrocochleography and cochlear blood flow during cochlear hypoxia in rabbits.

Authors:  Erdem Yavuz; Krzysztof Morawski; Fred F Telischi; Ozcan Ozdamar; Rafael E Delgado; Fabrice Manns; Jean-Marie Parel
Journal:  J Neurosci Methods       Date:  2005-04-25       Impact factor: 2.390

5.  Auditory disturbance as a prodrome of anterior inferior cerebellar artery infarction.

Authors:  H Lee; Y-W Cho
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

6.  Preventing internal auditory artery vasospasm using topical papaverine: an animal study.

Authors:  Krzysztof Morawski; Fred F Telischi; Faisal Merchant; Grzegorz Namyslowski; Grazyna Lisowska; Brenda L Lonsbury-Martin
Journal:  Otol Neurotol       Date:  2003-11       Impact factor: 2.311

7.  Recurrent audiovestibular disturbance initially mimicking Ménière's disease in a patient with anterior inferior cerebellar infarction.

Authors:  Jong-Ho Park; Hyeyun Kim; Hyun-Jeong Han
Journal:  Neurol Sci       Date:  2008-10-21       Impact factor: 3.307

8.  Response to Letter by Dr. Cristina Brandolini.

Authors:  Hyun-Ah Kim; Hyung Lee
Journal:  J Stroke       Date:  2017-05-31       Impact factor: 6.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.